ORCL vs RXST · P/E 31, rev $67.36B vs rev $64.6M
Oracle Corporation (ORCL) versus Rxsight Inc (RXST) — a side-by-side from cached financials, not a winner call.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Latest reported RXST revenue for 2026-06-30 was $64.6M. Net income was -$28.0M. RXST currently screens at market cap $198.3M.
ORCL currently screens at market cap $527.84B and trailing P/E 31.4. RXST currently screens at market cap $198.3M.
Not investment advice. Open the ORCL and RXST stock pages for the full models.
Not investment advice.